Cargando…
The Global Drug Facility as an intervention in the market for tuberculosis drugs
OBJECTIVE: To investigate funding for the Global Drug Facility since 2001 and to analyse the facility’s influence on the price of high-quality tuberculosis drugs. METHODS: Data on the price of tuberculosis drugs were obtained from the Global Drug Facility for 2001 to 2012 and, for the private sector...
Autores principales: | Arinaminpathy, Nimalan, Cordier-Lassalle, Thierry, Lunte, Kaspars, Dye, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431561/ https://www.ncbi.nlm.nih.gov/pubmed/26229188 http://dx.doi.org/10.2471/BLT.14.147256 |
Ejemplares similares
-
Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility
por: Lunte, Kaspars, et al.
Publicado: (2015) -
Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine
por: Fu, Han, et al.
Publicado: (2021) -
The number of privately treated tuberculosis cases in India: an estimation from drug sales data
por: Arinaminpathy, Nimalan, et al.
Publicado: (2016) -
The Potential Impact of Up-Front Drug Sensitivity Testing on India’s Epidemic of Multi-Drug Resistant Tuberculosis
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015) -
Management of tuberculosis by healthcare practitioners in Pakistan: A systematic review
por: Braham, Christy A., et al.
Publicado: (2018)